Newbury Acquisitions Fund

Newbury Pharmaceuticals is a Swedish specialty pharmaceutical company focused on the Nordic market. The company utilizes a hybrid business model that involves acquiring, developing, and commercializing a diverse portfolio of specialty medicines, including generics, value-added medicines, and biosimilars. Newbury targets therapeutic areas with high medical needs and limited competition, leveraging strategic partnerships to secure product rights and licenses. Its portfolio spans several key areas such as oncology, rare diseases, and neurology, with a focus on providing cost-effective and high-quality treatment options to healthcare systems in Scandinavia.